BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22047936)

  • 1. Psoriasis and Cardiovascular Disease: epidemiological studies.
    Ahlehoff O
    Dan Med Bull; 2011 Nov; 58(11):B4347. PubMed ID: 22047936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study.
    Ahlehoff O; Gislason GH; Lindhardsen J; Olesen JB; Charlot M; Skov L; Torp-Pedersen C; Hansen PR
    J Intern Med; 2011 Sep; 270(3):237-44. PubMed ID: 21362070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study.
    Ahlehoff O; Gislason GH; Jørgensen CH; Lindhardsen J; Charlot M; Olesen JB; Abildstrøm SZ; Skov L; Torp-Pedersen C; Hansen PR
    Eur Heart J; 2012 Aug; 33(16):2054-64. PubMed ID: 21840930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression following myocardial infarction--an overseen complication with prognostic importance.
    Larsen KK
    Dan Med J; 2013 Aug; 60(8):B4689. PubMed ID: 23905572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study.
    Ahlehoff O; Skov L; Gislason G; Lindhardsen J; Kristensen SL; Iversen L; Lasthein S; Gniadecki R; Dam TN; Torp-Pedersen C; Hansen PR
    J Intern Med; 2013 Feb; 273(2):197-204. PubMed ID: 22963528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
    Ahlehoff O; Gislason GH; Charlot M; Jørgensen CH; Lindhardsen J; Olesen JB; Abildstrøm SZ; Skov L; Torp-Pedersen C; Hansen PR
    J Intern Med; 2011 Aug; 270(2):147-57. PubMed ID: 21114692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study.
    Schjerning Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Lamberts M; Bjerring Olesen J; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
    Circulation; 2011 May; 123(20):2226-35. PubMed ID: 21555710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan Intervention For Endpoint reduction in hypertension study.
    Cicala S; de Simone G; Gerdts E; Dahlöf B; Lindholm LH; Kjeldsen SE; Devereux RB
    J Hypertens; 2010 Jun; 28(6):1134-40. PubMed ID: 20486280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The best of epidemiology and cardiovascular prevention in 2006].
    Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis after first-time myocardial infarction in patients with inflammatory bowel disease according to disease activity: nationwide cohort study.
    Kristensen SL; Ahlehoff O; Lindhardsen J; Erichsen R; Lamberts M; Khalid U; Nielsen OH; Torp-Pedersen C; Gislason GH; Hansen PR
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):857-62. PubMed ID: 25316773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative and positive predictive values of routine exercise testing in stable, medically-treated patients several years following a Q-wave myocardial infarction.
    Casella G; Pavesi PC; Niro MD; Bracchetti D
    Ital Heart J; 2001 Apr; 2(4):271-9. PubMed ID: 11374496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal artery stenosis predicts adverse cardiovascular and renal outcome in patients with peripheral artery disease.
    Amighi J; Schlager O; Haumer M; Dick P; Mlekusch W; Loewe C; Böhmig G; Koppensteiner R; Minar E; Schillinger M
    Eur J Clin Invest; 2009 Sep; 39(9):784-92. PubMed ID: 19522837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
    Kang S; Yang Y; Li CJ; Gao R
    Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptive use and cardiovascular disease: is the relationship real or due to study bias?
    Katerndahl DA; Realini JP; Cohen PA
    J Fam Pract; 1992 Aug; 35(2):147-57. PubMed ID: 1386621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes.
    Frederich R; Alexander JH; Fiedorek FT; Donovan M; Berglind N; Harris S; Chen R; Wolf R; Mahaffey KW
    Postgrad Med; 2010 May; 122(3):16-27. PubMed ID: 20463410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.